Objective,2,To observe the clinical efficacy of tuina therapy of regulating the lung and activating the spleen in the treatment of chronic cough (syndrome of lung and spleen qi deficiency) in children with mycoplasma pneumoniae infection.,Methods,2,Totally 72 children with chronic cough (syndrome of lung and spleen qi deficiency) after mycoplasma pneumoniae infection were randomly divided into the treatment group (,n,=36) and the control group (,n,=36). The control group was treated with azithromycin, and the treatment group was treated with tuina therapy of regulating the lung and activating the spleen combined with azithromycin. The course of treatment in both groups was 14 days. The clinical efficacy was observed. The changes of daytime cough score, nocturnal cough score, the total score of the cough and secondary symptom score were compared.,Results,2,① A total of 71 cases completed the trial, including 35 cases in the treatment group and 36 cases in the control group. ② The total main symptom effective rate and the total effective rate of secondary symptoms in the treatment group were 100.0% and 94.3% respectively, while those in the control group were 83.3% and 66.7% respectively. The clinical efficacy, the efficacy on the main symptoms and the efficacy on the secondary symptoms of the treatment group were better than those of the control group (,P,<,0.05). ③There were significant differences in the daytime cough score, nocturnal cough score, the total scores of cough and secondary symptom score within the two groups before and after treatment (,P,<,0.05), and there were significant differences in daytime cough, nocturnal cough, the total scores of cough and secondary symptom score between the two groups after treatment (,P,<, 0.05).,Conclusion,2,The tuina therapy of regulating the lung and activating the spleen is effective in the treatment of chronic cough (syndrome of lung and spleen qi deficiency) after mycoplasma pneumoniae infection, and it is worth popularizing.